Back to Search
Test Name REF LAB PD L1 LUNG (PEMBROLIZUMAB OR CEMIPLIMAB) IHC
Orderable CPT -
OVT 123002563
Synonyms -
Result Test Name QUEST PARAFFIN BLOCK NUMBER:
Laboratory QUEST LAB
Result Test Code 12386007405
Laboratory Test Name QUEST PD L1 LUNG (PEMBROLIZUMAB OR CEMIPLIMAB) IHC
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin embedded (FFPE) tissue block submitted in IHC specimen transport kit Alternative Specimen(s) 5 unstained charged(+) slides submitted in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimens.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Lung (Pembrolizumab or Cemiplimab) IHC - The PD-L1 pharmaDx qualitative assay is intended for use in the detection of PD-L1 in formalin-fixed paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC). PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying NSCLC patients who may be eligible for treatment with KEYTRUDA (pembrolizumab) or LIBTAYO (cemiplimab).
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature Specimen Stability Paraffin block Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Slides Room temperature: 30 days Refrigerated: 30 days Frozen: Unacceptable
Result Test Name QUEST COLLECTION SITE
Laboratory QUEST LAB
Result Test Code 123924779
Laboratory Test Name QUEST PD L1 LUNG (PEMBROLIZUMAB OR CEMIPLIMAB) IHC
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin embedded (FFPE) tissue block submitted in IHC specimen transport kit Alternative Specimen(s) 5 unstained charged(+) slides submitted in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimens.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Lung (Pembrolizumab or Cemiplimab) IHC - The PD-L1 pharmaDx qualitative assay is intended for use in the detection of PD-L1 in formalin-fixed paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC). PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying NSCLC patients who may be eligible for treatment with KEYTRUDA (pembrolizumab) or LIBTAYO (cemiplimab).
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature Specimen Stability Paraffin block Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Slides Room temperature: 30 days Refrigerated: 30 days Frozen: Unacceptable
Result Test Name QUEST ONCOLOGIST NAME:
Laboratory QUEST LAB
Result Test Code 123924780
Laboratory Test Name QUEST PD L1 LUNG (PEMBROLIZUMAB OR CEMIPLIMAB) IHC
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin embedded (FFPE) tissue block submitted in IHC specimen transport kit Alternative Specimen(s) 5 unstained charged(+) slides submitted in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimens.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Lung (Pembrolizumab or Cemiplimab) IHC - The PD-L1 pharmaDx qualitative assay is intended for use in the detection of PD-L1 in formalin-fixed paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC). PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying NSCLC patients who may be eligible for treatment with KEYTRUDA (pembrolizumab) or LIBTAYO (cemiplimab).
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature Specimen Stability Paraffin block Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Slides Room temperature: 30 days Refrigerated: 30 days Frozen: Unacceptable
Result Test Name QUEST ONCOLOGIST NAME:
Laboratory QUEST LAB
Result Test Code 12386014289
Laboratory Test Name QUEST PD L1 LUNG (PEMBROLIZUMAB OR CEMIPLIMAB) IHC
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin embedded (FFPE) tissue block submitted in IHC specimen transport kit Alternative Specimen(s) 5 unstained charged(+) slides submitted in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimens.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Lung (Pembrolizumab or Cemiplimab) IHC - The PD-L1 pharmaDx qualitative assay is intended for use in the detection of PD-L1 in formalin-fixed paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC). PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying NSCLC patients who may be eligible for treatment with KEYTRUDA (pembrolizumab) or LIBTAYO (cemiplimab).
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature Specimen Stability Paraffin block Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Slides Room temperature: 30 days Refrigerated: 30 days Frozen: Unacceptable
Result Test Name QUEST COLLECTION SITE
Laboratory QUEST LAB
Result Test Code 12386001727
Laboratory Test Name QUEST PD L1 LUNG (PEMBROLIZUMAB OR CEMIPLIMAB) IHC
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin embedded (FFPE) tissue block submitted in IHC specimen transport kit Alternative Specimen(s) 5 unstained charged(+) slides submitted in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimens.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Lung (Pembrolizumab or Cemiplimab) IHC - The PD-L1 pharmaDx qualitative assay is intended for use in the detection of PD-L1 in formalin-fixed paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC). PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying NSCLC patients who may be eligible for treatment with KEYTRUDA (pembrolizumab) or LIBTAYO (cemiplimab).
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature Specimen Stability Paraffin block Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Slides Room temperature: 30 days Refrigerated: 30 days Frozen: Unacceptable
Result Test Name QUEST PARAFFIN BLOCK NUMBER:
Laboratory QUEST LAB
Result Test Code 12386027129
Laboratory Test Name QUEST PD L1 LUNG (PEMBROLIZUMAB OR CEMIPLIMAB) IHC
Reportable Test Name -
Result LOINC 55752-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin embedded (FFPE) tissue block submitted in IHC specimen transport kit Alternative Specimen(s) 5 unstained charged(+) slides submitted in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimens.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Lung (Pembrolizumab or Cemiplimab) IHC - The PD-L1 pharmaDx qualitative assay is intended for use in the detection of PD-L1 in formalin-fixed paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC). PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying NSCLC patients who may be eligible for treatment with KEYTRUDA (pembrolizumab) or LIBTAYO (cemiplimab).
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature Specimen Stability Paraffin block Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Slides Room temperature: 30 days Refrigerated: 30 days Frozen: Unacceptable
Result Test Name QUEST PRIMARY TUMOR SITE:
Laboratory QUEST LAB
Result Test Code 123924778
Laboratory Test Name QUEST PD L1 LUNG (PEMBROLIZUMAB OR CEMIPLIMAB) IHC
Reportable Test Name -
Result LOINC 22035-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin embedded (FFPE) tissue block submitted in IHC specimen transport kit Alternative Specimen(s) 5 unstained charged(+) slides submitted in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimens.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Lung (Pembrolizumab or Cemiplimab) IHC - The PD-L1 pharmaDx qualitative assay is intended for use in the detection of PD-L1 in formalin-fixed paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC). PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying NSCLC patients who may be eligible for treatment with KEYTRUDA (pembrolizumab) or LIBTAYO (cemiplimab).
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature Specimen Stability Paraffin block Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Slides Room temperature: 30 days Refrigerated: 30 days Frozen: Unacceptable
Result Test Name QUEST PRIMARY TUMOR SITE:
Laboratory QUEST LAB
Result Test Code 12386007575
Laboratory Test Name QUEST PD L1 LUNG (PEMBROLIZUMAB OR CEMIPLIMAB) IHC
Reportable Test Name -
Result LOINC 22035-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin embedded (FFPE) tissue block submitted in IHC specimen transport kit Alternative Specimen(s) 5 unstained charged(+) slides submitted in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimens.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Lung (Pembrolizumab or Cemiplimab) IHC - The PD-L1 pharmaDx qualitative assay is intended for use in the detection of PD-L1 in formalin-fixed paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC). PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying NSCLC patients who may be eligible for treatment with KEYTRUDA (pembrolizumab) or LIBTAYO (cemiplimab).
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature Specimen Stability Paraffin block Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Slides Room temperature: 30 days Refrigerated: 30 days Frozen: Unacceptable
Result Test Name QUEST TUMOR PROPORTION SCORE
Laboratory QUEST LAB
Result Test Code 12386014281
Laboratory Test Name QUEST PD L1 LUNG (PEMBROLIZUMAB OR CEMIPLIMAB) IHC
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin embedded (FFPE) tissue block submitted in IHC specimen transport kit Alternative Specimen(s) 5 unstained charged(+) slides submitted in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimens.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Lung (Pembrolizumab or Cemiplimab) IHC - The PD-L1 pharmaDx qualitative assay is intended for use in the detection of PD-L1 in formalin-fixed paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC). PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying NSCLC patients who may be eligible for treatment with KEYTRUDA (pembrolizumab) or LIBTAYO (cemiplimab).
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature Specimen Stability Paraffin block Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Slides Room temperature: 30 days Refrigerated: 30 days Frozen: Unacceptable
Result Test Name QUEST INTERNAL NUMBER:
Laboratory QUEST LAB
Result Test Code 123924781
Laboratory Test Name QUEST PD L1 LUNG (PEMBROLIZUMAB OR CEMIPLIMAB) IHC
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) Formalin-fixed paraffin embedded (FFPE) tissue block submitted in IHC specimen transport kit Alternative Specimen(s) 5 unstained charged(+) slides submitted in IHC specimen transport kit Minimum Volume 5 slides Collection Instructions FFPE: State any other type of fixative used. A pathology report which includes the paraffin block number and both macroscopic and microscopic evaluation and diagnosis should be sent with the specimens.
Container Temp Room Temperature (1)
Container Volume -
Test Info PD-L1 Lung (Pembrolizumab or Cemiplimab) IHC - The PD-L1 pharmaDx qualitative assay is intended for use in the detection of PD-L1 in formalin-fixed paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC). PD-L1 IHC 22C3 pharmDx is indicated as an aid in identifying NSCLC patients who may be eligible for treatment with KEYTRUDA (pembrolizumab) or LIBTAYO (cemiplimab).
Shipping Instructions Transport Container IHC specimen transport kit Transport Temperature Room temperature Specimen Stability Paraffin block Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Slides Room temperature: 30 days Refrigerated: 30 days Frozen: Unacceptable